Use of fresh platelet-rich plasma as adjuvant therapy in post-operative joint surgery, via arthroscopy, Anacaona Medical Center, San Juan de la Maguana, Dominican Republic, January-July 2023

Abstract

Arthroscopic surgery has transformed orthopedics by offering minimally invasive procedures that reduce recovery time and risks. However, post-surgical complications can arise, which has led to the use of treatments such as platelet-rich plasma (PRP), which accelerates healing and improves tissue regeneration. The aim of this study was to describe the importance of PRP in patients undergoing arthroscopic surgery. A descriptive and prospective study was carried out in the Traumatology and Orthopedics service of the Anacaona Medical Center, San Juan de la Maguana, Dominican Republic, between January and July, 2023, with 65 patients who underwent surgery and who were administered PRP in the affected joint for one or two months. Of the patients, 56.9% were women and 51.0% were from urban areas. The main cause of injury was traffic accident (45.1%), affecting mainly hip, elbow and knee (25.5% each). The post-infiltration evolution was favorable in most cases in the first 10 days. It is concluded that the use of PRP after arthroscopic surgery favors recovery, reducing inflammation and infections, which makes it an effective option to improve postoperative results and minimize complications.